BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 282 filers reported holding BLUEBIRD BIO INC in Q3 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $171,696 | +6.6% | 66,469 | +35.7% | 0.00% | 0.0% |
Q2 2023 | $161,124 | +281.7% | 48,974 | +269.0% | 0.00% | – |
Q1 2023 | $42,208 | -62.4% | 13,273 | -18.3% | 0.00% | -100.0% |
Q4 2022 | $112,374 | +20.8% | 16,239 | +10.6% | 0.00% | 0.0% |
Q3 2022 | $93,000 | +86.0% | 14,679 | +22.5% | 0.00% | – |
Q2 2022 | $50,000 | -18.0% | 11,979 | -4.5% | 0.00% | – |
Q1 2022 | $61,000 | -60.1% | 12,538 | -18.0% | 0.00% | -100.0% |
Q4 2021 | $153,000 | -56.2% | 15,298 | -16.2% | 0.00% | -66.7% |
Q3 2021 | $349,000 | -54.3% | 18,266 | -23.4% | 0.00% | -57.1% |
Q2 2021 | $763,000 | +26.1% | 23,850 | +18.9% | 0.01% | 0.0% |
Q1 2021 | $605,000 | +11.4% | 20,065 | +59.8% | 0.01% | 0.0% |
Q4 2020 | $543,000 | -31.7% | 12,555 | -14.9% | 0.01% | -46.2% |
Q3 2020 | $795,000 | +16.1% | 14,754 | +31.5% | 0.01% | +18.2% |
Q2 2020 | $685,000 | +112.7% | 11,218 | +48.0% | 0.01% | +57.1% |
Q1 2020 | $322,000 | -39.2% | 7,581 | +23.4% | 0.01% | -12.5% |
Q4 2019 | $530,000 | +17566.7% | 6,141 | +38281.2% | 0.01% | – |
Q2 2018 | $3,000 | – | 16 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AlpInvest Partners B.V. | 46,264 | $3,958,000 | 7.80% |
RTW INVESTMENTS, LP | 151,594 | $12,969,000 | 4.03% |
APIS CAPITAL ADVISORS, LLC | 30,870 | $2,640,000 | 3.65% |
Parametrica Management Ltd | 4,084 | $349,000 | 2.20% |
Eventide Asset Management | 419,600 | $35,897,000 | 2.09% |
RA Capital Management | 167,367 | $14,318,000 | 2.06% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 483,000 | $41,321,000 | 1.60% |
Taylor Wealth Management Partners | 38,184 | $3,267,000 | 1.58% |
Orbimed Advisors | 1,188,900 | $101,710,000 | 1.03% |
CABOT WEALTH MANAGEMENT INC | 34,195 | $2,925,000 | 0.81% |